Unigestion Holding Sa Regeneron Pharmaceuticals, Inc. Transaction History

Unigestion Holding Sa

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$692.45 - $844.37 $449,400 - $547,996	-649 Reduced 72.51%	246 $202,000
Q2 2023 Jul 27, 2023	BUY	$700.03 - $830.35 $19,600 - $23,249	28 Added 3.23%	895 $643,000
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $612,006 - $664,460	867 New	867 $625,000
Q2 2021 Jul 29, 2021	SELL	$472.8 - $558.54 $3.44 Million - $4.06 Million	-7,271 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$446.73 - $548.2 $4.18 Million - $5.13 Million	-9,359 Reduced 56.28%	7,271 $3.44 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $6.34 Million - $8.05 Million	13,246 Added 391.43%	16,630 $8.03 Million
Q3 2020 Nov 10, 2020	BUY	$544.75 - $658.21 $1.84 Million - $2.23 Million	3,384 New	3,384 $1.89 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

Stay updated on Unigestion Holding Sa with notifications on news.